Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93


Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice.

Freeman KW, Welm BE, Gangula RD, Rosen JM, Ittmann M, Greenberg NM, Spencer DM.

Cancer Res. 2003 Dec 1;63(23):8256-63.


Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate.

Jin C, McKeehan K, Guo W, Jauma S, Ittmann MM, Foster B, Greenberg NM, McKeehan WL, Wang F.

Cancer Res. 2003 Dec 15;63(24):8784-90.


Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.

Feng S, Wang F, Matsubara A, Kan M, McKeehan WL.

Cancer Res. 1997 Dec 1;57(23):5369-78.


Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia.

Song Z, Wu X, Powell WC, Cardiff RD, Cohen MB, Tin RT, Matusik RJ, Miller GJ, Roy-Burman P.

Cancer Res. 2002 Sep 1;62(17):5096-105.


Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer.

Valve EM, Nevalainen MT, Nurmi MJ, Laato MK, Martikainen PM, Härkönen PL.

Lab Invest. 2001 Jun;81(6):815-26.


Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.

Sinha AA, Quast BJ, Reddy PK, Lall V, Wilson MJ, Qian J, Bostwick DG.

Exp Mol Pathol. 2004 Oct;77(2):153-9.


Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms.

Auguste P, Gürsel DB, Lemière S, Reimers D, Cuevas P, Carceller F, Di Santo JP, Bikfalvi A.

Cancer Res. 2001 Feb 15;61(4):1717-26.


Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride.

Sáez C, González-Baena AC, Japón MA, Giráldez J, Segura DI, Rodríguez-Vallejo JM, González-Esteban J, Miranda G, Torrubia F.

Prostate. 1999 Jul 1;40(2):83-8.


Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.

Ropiquet F, Giri D, Kwabi-Addo B, Mansukhani A, Ittmann M.

Cancer Res. 2000 Aug 1;60(15):4245-50.


Angiogenesis and prostate cancer: identification of a molecular progression switch.

Huss WJ, Hanrahan CF, Barrios RJ, Simons JW, Greenberg NM.

Cancer Res. 2001 Mar 15;61(6):2736-43.


Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition.

Acevedo VD, Gangula RD, Freeman KW, Li R, Zhang Y, Wang F, Ayala GE, Peterson LE, Ittmann M, Spencer DM.

Cancer Cell. 2007 Dec;12(6):559-71.


The tyrp1-Tag/tyrp1-FGFR1-DN bigenic mouse: a model for selective inhibition of tumor development, angiogenesis, and invasion into the neural tissue by blockade of fibroblast growth factor receptor activity.

Rousseau B, Larrieu-Lahargue F, Javerzat S, Guilhem-Ducléon F, Beermann F, Bikfalvi A.

Cancer Res. 2004 Apr 1;64(7):2490-5. Erratum in: Cancer Res. 2004 Oct 1;64(19):7181.


A potential autocrine role for vascular endothelial growth factor in prostate cancer.

Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C, Horsfall DJ, Tilley WD.

Cancer Res. 2002 Feb 1;62(3):854-9. Erratum in: Cancer Res 2002 Apr 1;62(7):2200.


Supplemental Content

Support Center